Events
Explore the INSIG Inc Events Calendar – your hub for upcoming meetings, conferences, courses and professional development opportunities in immunisation. These events bring nurses and health professionals together across Victoria, with something for both members and guests. Want more? Become an INSIG Inc member and unlock access to exclusive events and resources.
First Aid Management & Training
First Aid Management & Training -Nurse Immuniser Update Course
Provide an Emergency Response in an Immunisation Emergency
This course will update the skills and knowledge of the nurse immuniser to respond to an emergency event following immunisation.
Course Content
- Emergency responsibilities
- Recognition and management of adverse events following immunisation (AEFI)
- Providing appropriate emergency management of AEFI
- CPR – infants, children and adults, HLTAID009 – Provide Cardiopulmonary Resuscitation
- Infection control
- Reporting procedures
Special discount offered to INSIG Inc members.
To enquire CLICK HERE or call (03) 9894 1013
ACIPC -Vaccination Program in Aged Care 19 August 2026
Australasian College for Infection Prevention and Control (ACIPC)
Vaccination Program in aged care
Wednesday 19 August 2026, 2.00pm (AEST)
Speaker: Geraldine Feriks
Immunisation Coalition: Pneumococcal Update, Wednesday 19 August 2026
Learning outcomes:
- Review the epidemiology and burden of pneumococcal disease in Australia.
- Review the wide range of illnesses caused by pneumococcal disease.
- Review the different serotypes of Prevenar 20 and Capvaxive and why these are important.
- Highlight the current Australian recommendations for children and adolescents <18 years old and in adults aged 18 years and over.
- Be familiar with the updated PneumoSmart Tool to help identify patients due for pneumococcal disease vaccination.
- Describe the safety profile of Prevenar 20 and Capvaxive.
Date: Wednesday 19 August 2026
Time: 6:00 – 7:00pm AEST
Moderator: Dr Andrew Minton, PhD
Presenter: Dr Andrew Baird
Adult vaccination in practice with Arexvy & Shingrix
- Identify older adults who are eligible for RSV vaccination
- Educate patients on their individual risk of RSV disease and the efficacy and safety profile of AREXVY
- Vaccinate with confidence by learning practical steps to administer AREXVY in everyday practice
- Understand the risk and impact of shingles
- Recognise the importance of vaccinating adults ≥50 years of age
- Describe the clinical profile of SHINGRIX
- Develop strategies for implementing SHINGRIX discussions within your practice
2026 VSNA Conference
Victorian School Nurse Association Biennial Conference 2026 — Beyond the Classroom.
Step outside the health centre and into the real-world challenges of off-campus care. We’ll dive into complex medical needs, first aid on the move, legal considerations, and everything school health teams face beyond the school gates.
Designed for school nurses and first aiders, this high-impact day delivers practical professional learning, powerful networking, and access to top trade exhibitors.
Have something to share?
Delegates are encouraged to submit posters showcasing service improvements, innovative care approaches, or research — spark ideas, start conversations, and inspire change.
Learn. Connect. Share
Austin Immunisation Symposium (AIS2026) 27 August 2026
Join leading clinicians, researchers, pharmacists, nurses and healthcare professionals from across Australia for the Austin Health Immunisation Service National Symposium.
Explore the latest evidence, emerging trends and practical innovations shaping the future of immunisation through expert presentations, interactive discussions and valuable networking opportunities designed to enhance patient care and public health outcomes.
CLICK HERE for program
ISRV -The International Society for Respiratory Viruses’ Options XIII Conference for the Control of Influenza -30 August to 2 September 2026
On behalf of the International Society for Respiratory Viruses (ISRV), we are delighted to welcome you to the Options for the Control of Influenza XIII Conference, taking place 30 August – 2 September 2026 in Washington, DC at the Washington DC Convention Center.
The Options conference is the largest global scientific meeting focused on influenza prevention, control, and treatment. As with recent Options meetings, there will also be sessions about other respiratory viruses. In 2026, we will once again bring together the world’s leading experts in virology, clinical care, public health, and vaccine research to share the latest evidence, foster collaboration, and advance the global response to influenza.
Australia’s 2nd Vaccine Value Chain Conference (Sydney)
Australia’s 2nd Vaccine Value Chain Conference 2026 in Sydney.
Building on the strong foundations of AVVCC24, this conference brings together leaders from government, industry, academia, research, investment and the broader immunisation community to strengthen collaboration across the end to end vaccine value chain. At a time of rapid geopolitical change, evolving policy reform and renewed focus on national health resilience, it is more important than ever to align our collective efforts to reinforce the value of vaccines and infectious disease control.
AVVCC26 provides a vital platform to enhance public private partnerships, share knowledge, shape practical recommendations and support Australia’s ambition to remain a globally relevant and competitive contributor to the vaccine ecosystem. We look forward to fostering meaningful dialogue, enabling new collaborations and driving tangible outcomes that will strengthen health impact and innovation across the nation.
17th National Paediatrics Bioethics Conference, 2-4 September 2026
Join for the 17th National Paediatrics Bioethics Conference. The theme for 2026 is The ‘Best Interests’ Standard: Myth, Mandate or Moving Target?
Date 2-4 September, 2026
Location -Ella Latham Theatre, Royal Children’s Hospital
Immunisation Coalition: 2026 RSV webinar, 3 September 2026
This webinar will provide an overview of RSV epidemiology, disease burden and immunisation rates for pregnant women, infants upto 2 years old, and an update on the newly NIP listed RSV vaccine Arexvy, for first nations people 60 years and over and adults 75 years and over. Other areas covered will include safety and efficacy, and initiatives to increase vaccination rates across the different age groups.
This information will be of interest to healthcare professionals that provide advice and are active in recommending vaccination and immunise against RSV in pregnant women, babies, young infants, and older adult populations.
Speaker: A/Prof Nusrat Homaira
Moderator: Dr Andrew Baird
Date : September 3, 2026
Time: 6.30 – 8.30pm (AEST)